M701 specifically induces potent cytotoxicity in EpCAM-positive tumor cells, with minimal effects on EpCAM-negative cells, highlighting its potential as a targeted therapeutic agent for EpCAM-expressing cancers. Here, EPCAM is linked to neoplasm.